We want to understand the impact of our research and how it helps achieve the Medical Research Council’s (MRC) mission to improve human health. Performance monitoring and evaluation is how we understand this impact, as it seeks to reveal the quality of the research we fund, and the processes needed to expand its impact.
How MRC evaluates research
We continually improve the monitoring of input and output of our research portfolio and the methodology and techniques for assessing research impact. Additionally, we collaborate with other research funding agencies to evolve stronger principles and policies to ensure robust evaluation. These include openness and use of the FAIR principles.
Recent MRC monitoring and evaluation reports
10 year MRC translation research evaluation report
The 10 year MRC translation research evaluation report looks at MRC’s support for translational research and the progress made since the MRC increased its commitment to translation in the academic year 2008 to 2009.
The evaluation explores:
- what MRC translational research has delivered
- the national and international context for translational research
- issues to address in future funding.
Review of Health Systems Research Initiative
The joint funders of Health Systems Research Initiative commissioned an independent review of the scheme. This was to understand the impact of Health Systems Research Initiative (HSRI) funding and to determine if it was delivering its core aims.
Clinical Research Infrastructure Initiative
In 2015, the MRC Clinical Research Infrastructure Initiative (CRII) set out to fund innovative technologies in areas of strategic opportunity. This report reviews the outputs and outcomes of this initiative and discusses the insights that might be applied to future infrastructure funding initiatives.
What’s It Worth
Analysis of the economic benefits of medical research:
- Cardiovascular disease and mental health: 2008
- Cancer: 2014 on BMC Medicine
- Musculoskeletal disease: 2018 on BMC Medicine
- Musculoskeletal disease policy briefing.
The impact of UK research in Europe
The impact of UK research in Europe (2017) report identifies some of the main ways in which UK research contributes to medical progress, it highlights the benefit this has delivered for EU science, and ultimately how this has improved the health of patients across the EU.
We have a number of available databases recording research activity at an individual, national and global level that offer opportunities for analysis of the research landscape by outcome, by field, and by location. Data from these resources combined with other information form the basis for our evaluation reports.
Ten years of outcomes from 2011 to 2020 reported by MRC-funded projects including:
- 117,000 publications
- 22,600 collaborations
- more than £14.3 billion of further funding
- 10,100 research materials.
UK Health Research Classification System (HRCS)
The HRCS is used to classify biomedical research awards by area of health/disease and the type of research being carried out. The most recent UK report (PDF, 6.9MB) in 2018 is the largest ever analysis of the UK health research funding landscape, covering 146 organisations, over 22,000 awards and an estimated £4.8 billion spend in 2018.
UK and global research funding databases
Previous evaluation reports
- Next destinations
- Early career clinical academics
- Career movement between academia and business (PDF, 775KB)
- Outcomes and future approaches for prevention research
- Interdisciplinary research review (2016)
- Kings Policy Institute analysis of the Association of Medical Research Charities (AMRC) output data (PDF, 2.4MB)
- Strategy for UK regenerative medicine (2012)
- Stem Cell portfolio analysis (2007)
- Review of nutrition and energy balance (2008)
- What is the relationship between public and private investment in science and innovation? (2015) (PDF, 13.7MB)
MRC impact reports
Outputs, outcomes and impact of MRC research
Last updated: 31 March 2022